REHMANN CAPITAL ADVISORY GROUP Gilead Sciences, Inc. Transaction History

REHMANN CAPITAL ADVISORY GROUP portfolio value:

$766,743
portfolio value

REHMANN CAPITAL ADVISORY GROUP quarter portfolio value change:

-0.19%
quarter

Gilead Sciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +8.74% 999 shares 60.31K $61.69 12.42K
Q2 2022 share Increase +23.26% 2.15K shares 140.46K $61.81 11.42K
Q1 2022 share Decrease -19.88% -2.3K shares -277.64K $59.45 9.27K
Q4 2021 share Increase +4.40% 488 shares 69.34K $73.36 11.57K
Q3 2021 share Decrease -10.33% -1.27K shares -77.59K $69.85 11.08K
Q2 2021 share Increase +3.54% 423 shares 67.17K $68.17 12.36K
Q1 2021 share Decrease -4.04% -503 shares 59.83K $63.33 11.93K
Q4 2020 share Decrease -47.76% -11.37K shares -780.10K $56.43 12.44K
Q3 2020 share Increase +75.26% 10.22K shares 459.35K $60.52 23.81K
Q2 2020 share Increase +6.98% 887 shares 95.93K $72.94 13.58K
Q1 2020 share Increase +9.27% 1.07K shares 212.9K $70.22 12.70K
Q3 2019 share Decrease -1.29% -152 shares -58.86K $58.4 11.62K
Q2 2019 share Decrease -1.09% -130 shares 21.62K $61.67 11.77K
Q1 2019 share Increase +1.73% 203 shares 41.97K $58.79 11.90K
Q4 2018 share Decrease -11.83% -1.57K shares -292.78K $56.02 11.70K
Q3 2018 share Decrease -4.68% -651 shares 38.42K $68.57 13.27K
Q2 2018 share Decrease -39.33% -9.02K shares -743.59K $62.43 13.92K
Q1 2018 share Decrease -3.05% -723 shares 34K $65.91 22.95K
Q4 2017 share Decrease -3.07% -750 shares -283K $62.19 23.67K
Q3 2017 share Increase +4.19% 982 shares 320K $69.84 24.42K
Q2 2017 share Decrease -3.44% -836 shares 10K $60.63 23.44K
Q1 2017 share Increase +22.28% 4.42K shares 227K $57.72 24.27K
Q4 2016 share Increase +32.53% 4.87K shares 237K $60.39 19.85K
Q3 2016 share Decrease -21.00% -3.98K shares -397K $66.31 14.98K
Q2 2016 share Decrease -5.92% -1.19K shares -270K $69.49 18.96K
Q1 2016 share Increase +4.12% 798 shares -107K $76.1 20.15K